The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants

Trial Profile

The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Dec 2016

At a glance

  • Drugs Nitric oxide (Primary) ; Nitrogen
  • Indications Bronchopulmonary dysplasia
  • Focus Therapeutic Use
  • Sponsors Ikaria Holdings; Mallinckrodt Inc.
  • Most Recent Events

    • 03 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 21 May 2015 Planned End Date changed from 1 Mar 2015 to 1 Jun 2015, according to ClinicalTrials.gov record.
    • 25 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top